Cognition Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $372 |
Gross Profit | -67 | -58 | 306 |
EBITDA | -6,967 | -9,083 | -8,066 |
EBIT | -7,034 | -9,141 | -8,132 |
Net Income | -7,041 | -9,151 | -8,141 |
Net Change In Cash | 0 | 0 | 372 |
Free Cash Flow | -6,000 | -7,244 | -5,486 |
Cash | 28,533 | 34,671 | 29,922 |
Basic Shares | 40,062 | 33,735 | 30,776 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -252 | -235 | -93 | -98 |
EBITDA | -25,509 | -21,134 | -13,382 | -5,989 |
EBIT | -25,761 | -21,369 | -13,475 | -6,087 |
Net Income | -25,788 | 757 | -10,285 | -10,072 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -13,158 | |||
Free Cash Flow | -16,165 | -18,704 | -3,658 | -3,443 |
Cash | 29,922 | 41,562 | 54,721 | 5,189 |
Basic Shares | 30,029 | 28,991 | 22,230 | 21,936 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.25 |
2024-06-30 | -$0.18 |
2024-03-31 | -$0.27 |
2023-12-31 | -$0.27 |
